Cellectis S.A. (CLLS)
Cellectis S.A. Statistics
Share Statistics
Cellectis S.A. has 100.29M shares outstanding. The number of shares has increased by 46.66% in one year.
Shares Outstanding | 100.29M |
Shares Change (YoY) | 46.66% |
Shares Change (QoQ) | 66.03% |
Owned by Institutions (%) | 12.75% |
Shares Floating | 89.98M |
Failed to Deliver (FTD) Shares | 1.12K |
FTD / Avg. Volume | 0.31% |
Short Selling Information
Short Interest | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -4.9 and the forward PE ratio is -1.52. Cellectis S.A.'s PEG ratio is 0.06.
PE Ratio | -4.9 |
Forward PE | -1.52 |
PS Ratio | 4.34 |
Forward PS | 2.7 |
PB Ratio | 1.37 |
P/FCF Ratio | 9.41 |
PEG Ratio | 0.06 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Cellectis S.A..
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.7.
Current Ratio | 1.73 |
Quick Ratio | 1.73 |
Debt / Equity | 0.7 |
Debt / EBITDA | -9.67 |
Debt / FCF | 4.78 |
Interest Coverage | -7.99 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $192.16K |
Profits Per Employee | $-170.19K |
Employee Count | 216 |
Asset Turnover | 0.11 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -47.35% in the last 52 weeks. The beta is 3.38, so Cellectis S.A.'s price volatility has been higher than the market average.
Beta | 3.38 |
52-Week Price Change | -47.35% |
50-Day Moving Average | 1.35 |
200-Day Moving Average | 1.81 |
Relative Strength Index (RSI) | 53.7 |
Average Volume (20 Days) | 360.33K |
Income Statement
In the last 12 months, Cellectis S.A. had revenue of 41.51M and earned -36.76M in profits. Earnings per share was -0.37.
Revenue | 41.51M |
Gross Profit | 41.51M |
Operating Income | -59.55M |
Net Income | -36.76M |
EBITDA | -9.46M |
EBIT | -29.31M |
Earnings Per Share (EPS) | -0.37 |
Balance Sheet
The company has 143.25M in cash and 91.46M in debt, giving a net cash position of 51.79M.
Cash & Cash Equivalents | 143.25M |
Total Debt | 91.46M |
Net Cash | 51.79M |
Retained Earnings | -329.61M |
Total Assets | 383.54M |
Working Capital | 120.8M |
Cash Flow
In the last 12 months, operating cash flow was 22.99M and capital expenditures -3.84M, giving a free cash flow of 19.15M.
Operating Cash Flow | 22.99M |
Capital Expenditures | -3.84M |
Free Cash Flow | 19.15M |
FCF Per Share | 0.19 |
Margins
Gross margin is 100%, with operating and profit margins of -143.48% and -88.57%.
Gross Margin | 100% |
Operating Margin | -143.48% |
Pretax Margin | -88.57% |
Profit Margin | -88.57% |
EBITDA Margin | -22.8% |
EBIT Margin | -143.48% |
FCF Margin | 46.13% |
Dividends & Yields
CLLS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for CLLS is $6, which is 331.7% higher than the current price. The consensus rating is "Buy".
Price Target | $6 |
Price Target Difference | 331.7% |
Analyst Consensus | Buy |
Analyst Count | 3 |
Scores
Altman Z-Score | -0.67 |
Piotroski F-Score | 5 |